Log in

Splicing in two skeletal muscle transcripts correlates with clinical phenotype in myotonic dystrophy type 1 patients

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Harper PS, Brook JD, Newman E. Myotonic dystrophy. London; New York: W.B. Saunders; 2001.

  2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of a transcript encoding a protein kinase family member. Cell 68(4):799–808

    Article  CAS  PubMed  Google Scholar 

  3. Philips AV, Timchenko LT, Cooper TA (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280(5364):737–741

    Article  CAS  PubMed  Google Scholar 

  4. Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH et al (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488(7409):111–115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang G-S, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8(10):749–761

    Article  CAS  PubMed  Google Scholar 

  6. Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S et al (2013) Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol 74(6):862–872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Index IDMC-10. Programme at a glance 17. Poster Presentation Abstracts 95 Author index 218 Attendees Contact Information 245 Notes PDF [Internet]. [cited 2018 Sep 17]. Available from: https://docplayer.net/27797227-Index-idmc-10-programme-at-a-glance-17-poster-presentation-abstracts-95-author-index-218-attendees-contact-information-245-notes-260.html

  8. Mendell JR, Florence J (1990) Manual muscle testing. Muscle Nerve 13(Suppl):S16-20

    Article  PubMed  Google Scholar 

  9. Hébert LJ, Remec J-F, Saulnier J, Vial C, Puymirat J (2010) The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study. BMC Musculoskelet Disord 11:72

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bouchard J-P, Cossette L, Bassez G, Puymirat J (2015) Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases. J Neurol 262(2):285–293

    Article  CAS  PubMed  Google Scholar 

  11. Kierkegaard M, Tollbäck A (2007) Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord NMD 17(11–12):943–949

    Article  PubMed  Google Scholar 

  12. Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C et al (2010) Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 257(1):91–97

    Article  CAS  PubMed  Google Scholar 

  13. Henricson E, Abresch R, Han JJ, Nicorici A, Goude Keller E, de Bie E et al (2013) The 6-minute walk test and person-reported outcomes in boys with Duchenne muscular dystrophy and typically develo** controls: longitudinal comparisons and clinically-meaningful changes over one year. PLoS Curr 8:5

    Google Scholar 

Download references

Funding

This study was supported by Muscular Dystrophy UK and Myotonic Dystrophy Support Group (MDSG), UK and by the Polish National Science Center Grants: 2014/13/B/NZ5/03214, 2019/33/B/NZ5/02473 and 2020/39/B/NZ3/01811 (to M Wojciechowska). Muscular Dystrophy UK, MC3/1070 (to Saam Sedehizadeh).  

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saam Sedehizadeh.

Ethics declarations

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standards

The regional ethics committee approved the use of human participants for this study (Nottingham REC approval no. 13/EM/0173). Written informed consent was obtained from all participating patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sedehizadeh, S., Wojciechowska, M., Ketley, A. et al. Splicing in two skeletal muscle transcripts correlates with clinical phenotype in myotonic dystrophy type 1 patients. J Neurol 269, 2784–2787 (2022). https://doi.org/10.1007/s00415-021-10917-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10917-8

Navigation